Join us for the Annual Interstitial Lung Disease Interdisciplinary Network (ILD-IN) Conference on October 5th and 6th, 2025, at Edgbaston Park Hotel in Birmingham.
This conference brings together experts and enthusiasts in the field of interstitial lung diseases to explore topics such as diagnosis, supportive care, immunotherapy, and career development. Don’t miss this opportunity to connect, learn, and advance our understanding of ILD.
The Full Conference registration will include one night’s accommodation.
5th-6th October 2025
Edgbaston Park Hotel,
53 Edgbaston Park Road, Birmingham, B15 2RS
Become a Sponsor!
We’re currently welcoming sponsors for our upcoming conference. This is a great opportunity to showcase your brand, connect with industry leaders, and support an impactful event.
Interested in partnering with us? View our Sponsorship Brochure here or contact us at info@ild-in.org.uk
We’d love to hear from you!
Click on each speaker to read their biographies.
Rasleen (Ras) Kahai is a Highly Specialist Respiratory Dietitian at Royal Brompton Hospital (part of Guy’s and St Thomas’ NHS Foundation Trust). Graduating from King’s College London, Ras led the first known research on dietetic care for malnourished patients with ILD. She also runs a respiratory dietetic support group nationwide. Ras sits on Council of Healthcare Professionals for Asthma + Lung UK and is also a trustee for the Alexandra Rose Charity which provides families on low incomes access to fresh fruit & vegetables.
Dr Nazia Chaudhuri is a respiratory physician with a specialist interest in interstitial lung disease (ILD). She is senior clinical lecturer at Ulster University and is lead of the Northern Ireland ILD network. She is chair of the British Thoracic Society (BTS) ILD registry working group and was chair of the BTS interstitial and rare lung disease specialist advisory group from Nov 2020 to 2023. She is also a member of the European Respiratory Society (ERS) ILD long range planning committee, an ERS ILD mentor and has just been appointed as the secretary of the ERS idiopathic interstitial pneumonia ILD assembly. She is on the Irish Thoracic Society council and ILD working group. She is a trustee of the patient charity Pulmonary Fibrosis Northern Ireland (PFNI) and the NI rare disease partnership. She graduated from the University of Leeds with an honours degree in medicine and a BSc honours in genetics. She performed a PhD and published her work looking at the cellular interactions and signalling in response to infection and air pollution. She is the principal investigator on a number of clinical research trials (>20 over 5 years) in idiopathic pulmonary fibrosis (IPF) and was the UK Chief Investigator of a major clinical trial on progressive ILDs and a trial in IPF. She is collaborator on a number of grants exceeding £5 million. She is also co-applicant for a British Lung foundation grant for a study in Sarcoidosis. Dr Chaudhuri has published her experience in prescribing antifibrotics and delivering MDT care and has presented over 40 abstracts pertaining to IPF, antifibrotics and the importance of a multi-disciplinary team approach at all major respiratory conferences. She is collaborator on a number of grants and has co-authored over 50 peer reviewed articles. You can view Dr Chaudhuri’s full biography on https://pure.ulster.ac.uk/en/persons/nazia-chaudhuri.
Joshua is a Highly Specialised Clinical Scientist with a special interest in Interstitial Lung Disease. At Wythenshawe Hospital’s North West Lung Centre he works closely with one of the country’s biggest specialised ILD teams, performing diagnostic and disease monitoring assessments with our patients. He is a keen patient advocate as well as having a longstanding passion for clinical research both in the respiratory field and other areas of medicine. Alongside his clinical role and ILD-IN commitments, he has a particular interest in education and training development. He is an honorary lecturer and teaching lead for the national Practitioner and Scientist Training Programmes and as part of his commitment to clinical excellence, he has recently completed the Mary Seacole Leadership Programme with the NHS Academy. He joined the ILD-IN with the hope of providing scientific input to the network as we help to shape and influence the direction of ILD care within the UK. The role of clinical scientists is often greatly under recognised and he hopes to raise awareness of the key part we play in the ILD patient pathway. He is originally from Newcastle and the Geordie accent seems to be his most widely recognised trait (aside from the mighty Newcastle United Football Club).
We invite submission of abstracts for presentation at the ILD-IN Annual Conference 2025. Please review abstract guidance and submit your abstract using the form below by 4th August 2025 at 11:59pm.
The ILD Interdisciplinary Network (ILD-IN) aims to provide a supportive network for health professionals of all disciplines working in interstitial lung diseases. ILD-INs purpose is, to provide support, promote ILD specialty practice through education and professional development and to influence the policy of ILD care.
Annual ILD-IN Conference 2025
The 2024 conference was held on 6–7th October and has now passed.
Thank you to all our attendees, speakers and sponsors. Full details of the next annual conference will be available here soon!
Save The Date For 2025
The ILD Interdisciplinary Network (ILD-IN) aims to provide a supportive network for health professionals of all disciplines working in interstitial lung diseases. ILD-INs purpose is, to provide support, promote ILD specialty practice through education and professional development and to influence the policy of ILD care.